Lyme disease situation confirmed in Nepal: Himalayan Occasions Op-Erectile dysfunction

Walk in lab

The very first laboratory-confirmed Lyme disease situation continues to be reported in Nepal, based on an Op-Erectile dysfunction piece within the Himalayan Occasions by coordinator from the clinical research unit, Sukraraj Tropical & Infectious Disease Hospital, Dr. Sher Bahadur Pun Tuesday, prompting a notice for health health care providers and policy makers in the united states.

tickUsing its abdomen engorged having a host bloodstream meal, this picture depicts a lateral, or side look at a lady blacklegged, or deer tick, Ixodes scapularis/CDC

Based on Dr. Pun, the individual was a 32-years old individual that visited the hospital complaining of severe fatigue, discomfort, numbness and tingling sensation in arm.

It’s also noted that at least four other tick bite cases have visited a healthcare facility during the last couple of several weeks however, there’s no symbol of Lyme testing results on these patients.

A present qualifying criterion for laboratory proper diagnosis of Lyme disease isn’t achievable, costly and isn’t easily available in Nepal. This may be among the primary causes of vast variations in the amount of Lyme disease reported among developed and least civilized world.

Pun reports that ticks that carry Lyme bacteria are prevalent, specifically in Himalayan region asia, meaning Lyme disease may have been vastly underreported in India.

Save 20%! Statue of Liberty Bateaux Lunch Cruise Luxury Sightseeing


10 Most Significant Infectious Disease Tales of 2017: Outbreak News Today

I haven’t done a annual “Top 10” listing of the main infectious disease news tales since 2013 which is the very first on this web site.

The amount of important and newsworthy occasions of 2017 are plenty of and also to narrow it lower to 10 is really a challenge.

Some might have different tips on what constitutes the very best 10 and my list is dependant on covering infectious disease news since 2009.

The Very Best 10 Infectious Disease and Outbreak News tales of 2013

Anyway, here it is…

10. Getting ever nearer to eradication

Smallpox is the foremost and only human infectious disease to become eradicated. Thanks to some campaign of universal vaccination the final naturally sourced situation of smallpox is at October 1977 in Somalia. 2 yrs later the planet Health Organization (WHO) certified it as being eradicated. It was sanctioned through the World Health Set up (WHA) on May 1980.

Guinea worm Image/Video Screen ShotGuinea earthworm
Image/Video Screen Shot

There’s two other infectious illnesses which are getting so nearer to this massive achievement and also the finish is within sight–polio and guinea earthworm disease.

Polio cases have decreased by over 99% since 1988, from your believed 350,000 cases then, to 37 reported cases in 2016. In 2017, time (of WPV-1 cases) has dropped to 19 (7 in Pakistan and 12 in Afghanistan) through 12 ,. 19 because of vaccinations.

Guinea Earthworm Disease is with an equally miraculous track because it will get nearer to eradication. In 1986, there have been an believed 3.5 million cases in 21 countries in Africa and Asia. Today, time continues to be reduced by greater than 99.99 %.

Through March. 31, 26 cases happen to be reported from two countries (Chad- 14 and Ethiopia- 12). No vaccine or treatment are available for Guinea earthworm infection in humans. Rather, the traditional disease has been easily wiped out mainly through community-based interventions to teach and alter behavior, for example teaching individuals to filter all consuming water and stopping contamination by continuing to keep patients from entering ponds.

Image/geralt via pixabayImage/geralt via pixabay

9. Measles in Europe

This vaccine avoidable disease has truly raised it’s ugly mind in Europe beginning at the end of 2016 and thru all 2017.

Some 14,000 cases happen to be reported around the continent with Romania, Italia and Germany to be the most affected. Some 87 percent of individuals infected were unvaccinated.

LISTEN: Anti-vaccine arguments rebutted

8. Lyme disease developments

There is some important developments concerning the most typical vector-borne disease in america in 2017.

There’s been more political will to consider this tick borne disease as evidence this month through the first meeting of the Tick-Borne Disease Working Group.

Additionally, Valneva was granted FDA Fast Track designation for his or her Lyme disease vaccine candidate and important research was printed that found that the Lyme bacteria, Borrelia burgdorferi survive a 28-day span of antibiotics when treated several weeks after infection. Additionally, the research also measured the antibody immune reaction to the bacteria both pre- and publish- treatment, because this is how current diagnostics typically evaluate Lyme disease in humans.

It was just part of the happenings in the realm of Lyme disease.

LISTEN: Lyme disease: New information on Borrelia burgdorferi persistence

7. The Dengvaxia debacle

Because the announcement at the end of 2015 of Mexico approving the dengue vaccine, Dengvaxia by Sanofi Pasteur, about a dozen or even more countries approved the “milestone” vaccine.

The Philippines, the very first Asian country to approve the vaccine, folded it in pressure in 2016. From that point until lately, some 730,000 children were vaccinated.

Then came the announcement from Sanofi Pasteur on November. 29 that revealed that there’s an elevated chance of severe dengue and hospitalization many years after vaccination among individuals all age ranges who was not uncovered to dengue just before vaccination.

This motivated the Philippines to place the dengue vaccination program on hold. Since that time there’s been an activity Pressure produced and far putting the blame at who’s to blame.

meningitis epidemicsAfrican meningitis Belt/CDC

6. African meningitis belt

A large number of meningococcal meningitis C cases were reported within the African meningitis belt with Nigeria, Niger, Burkina Faso and Mali seeing a number of these cases. Nigeria saw greater than 1100 fatalities.

Just a week ago, the planet Health Organization cautioned of the approaching Men C epidemic in 2018 however, in addition, vaccine shortages happen to be noted.

5. Hepatitis A

Outbreaks in Europe and also the US happen to be reported among men who have relations with men (MSM) and destitute people. Vaccine shortages happen to be reported within this situation also.

4. Running from antibiotics

A WHO report in September shook people up a little with a few reality of the real crisis looming. The report,  Antibacterial agents in clinical development – an research into the antibacterial clinical development pipeline, including tuberculosis  showed a significant insufficient new antibiotics under development to combat the growing threat of antimicrobial resistance.

Officials observe that the majority of the drugs presently within the clinical pipeline are modifications of existing classes of antibiotics and therefore are only short-term solutions. The report found very couple of potential treatments for individuals antibiotic-resistant infections recognized by WHO as posing the finest threat to health, including drug-resistant t . b which kills around 250 000 people every year.

The report identifies 51 new antibiotics and biologicals in clinical development to deal with priority antibiotic-resistant pathogens however, only 8 are classed by WHO as innovative treatments which will increase the value of the present antibiotic treatment arsenal.


3. Venezuela

Venezuela is within turmoil regardless of what position your perception. Infectious illnesses is a position.

In 2016, Venezuela saw probably the most malaria cases since 1971 and that 30 percent more children died before their first birthday and 64 percent more women died while pregnant or within 42 days following childbirth in 2016 when compared with 2015.

In 2017, we had a significant uptick in measles and also the very harmful vaccine avoidable disease, diphtheria.

Situations are not searching good and that i don’t expect much great news in 2018.

2. Madgascar plague

Plague in Madagascar isn’t unusual and countless cases, mainly bubonic plague is reported yearly.

However, an unparalleled outbreak of plague in Madagascar, which began on 1 August 2017 led to some 2,500 cases and most 200 deaths.

Nearly eight from 10 cases were the greater harmful and person-to-person transmissible pneumonic, or lung plague.

At the begining of December, WHO reported the outbreak have been contained.

LISTEN: Pandemic versus epidemic: What’s the main difference and how come it matter?

1. The Yemen crisis

Many years of war, Saudi-brought airstrikes and blockades has brought to some huge humanitarian crisis in Yemen, the poorest country in the centre East.

Since Apr. 27, 1,013,260 cholera cases happen to be reported, including 2233 deaths. The outbreak has rapidly surpassed Haiti because the greatest since modern records started in 1949.

Diphtheria has witnessed an upsurge using more than 300 cases and 35 deaths being reported previously three several weeks.

Based on the 2018 Humanitarian Needs Overview, 16.4 million individuals 215 districts across Yemen lack sufficient use of healthcare – 9.3 million who have been in acute need. This presents an extreme increase of 79.3% since late 2014.



Lyme disease: New information on Borrelia burgdorferi persistence

Lyme disease is among the most typical infectious illnesses within the U . s . States with about 329,000 new cases every year, statistically released in 2015 through the CDC. Lyme disease is really a potentially disabling infection brought on by bacteria transmitted with the bite of the infected tick to individuals and pets.

The effectiveness and recognized regimen of antibiotic strategy to Lyme disease is a reason for significant contention among physicians and patients.

Recently printed research finds the Lyme bacteria, Borrelia burgdorferi survive a 28-day span of antibiotics when treated several weeks after infection. Additionally, the research also measured the antibody immune reaction to the bacteria both pre- and publish- treatment, because this is how current diagnostics typically evaluate Lyme disease in humans.

Lead author from the study, Monica Embers, PhD became a member of me to go over the study and it is implications. Dr Embers is an assistant professor of microbiology and immunology at Tulane College Med school and an advisor for that San Francisco Bay Area Lyme Foundation.

Show notes:

Related podcasts:

Borrelia burgdorferi spirochetes/CDCBorrelia burgdorferi spirochetes/CDC

Cannabinoid nutrition for Happy Healthy Pets

Intro music: “Rapture” by Ross Bugden

Australia: Medical officials support removing ‘Lyme disease’ from discussions with patients–‘unhelpful and divisive’

Around Australia, the subject of Lyme disease is a growing issue recently with patients discussing their tales about struggling with debilitating symptom complexes related to ticks.


The Australian Government Department of Health started engaging with patients and advocacy groups at the begining of 2013 to go over the concerns about Lyme borreliosis, also referred to as Lyme disease.

Now, a Senate inquiry into Growing proof of a growing tick-borne ailment that leads to a Lyme-like illness for a lot of Australian patients conducted through the Senate Community Matters References Committee culminated within the Committee’s final report, printed on November. 9,  building around the interim report tabled in May 2016.

The report led to 12 recommendations in the committee and also the Australian government’s response.

One of the recommendations include increased funding for research into tick-borne pathogens and a  epidemiological assessment from the prevalence of suspected tick-borne illness around australia.

Recommendation 9 involved how physicians along with other doctor should address suspected tick-borne illness.

“Consistently adopt someone-centric approach that focusses on individual patient signs and symptoms, as opposed to a disease label and take away ‘chronic Lyme disease’, ‘Lyme-like illness’ and other alike ‘Lyme’ phrases from diagnostic discussions.”

The federal government (health department) response agreed:

The department strongly supports removing the terms “Lyme Disease”, “Lyme disease-like Illness” and “Chronic Lyme Disease” from diagnostic discussions. They’re unhelpful and divisive.

At the moment, there’s not really a obvious agreed alternative nomenclature. The word adopted through the Committee “suspected tick-borne disease” is presumptive and is divisive. The department provides make use of the term “Debilitating Symptom Complexes Related to Ticks” (DSCATT) which National Medical and health Research Council (NHMRC) has adopted to explain its targeted Demand Research (TCR), to explain the heterogeneous nature from the debilitating symptom subgroups with acknowledgement that ticks could have a role.

Purchase One ZQuiet at $79.95 + S&H, Acquire One Half Off!


Lyme testing: Ionica Sciences and Global Lyme Alliance partner to build up IonLyme

Global Lyme Alliance (GLA), the key 501(c)(3) focused on conquering Lyme disease through good research, education and awareness, today announced it has partnered with Ionica Sciences, an Ithaca, New You are able to biotechnology company to accelerate the introduction of a very sensitive Lyme disease diagnostic test.

The brand new test, known as IonLyme™, targets Lyme disease microbial proteins and it is poised to change the rate and precision of diagnosis over existing tests. The process is exclusive, distinguishing Ionica Sciences’ technology all other Lyme tests available on the market. The approach allows earlier recognition of infections than is presently possible. Furthermore, it is also quickly adapted to identify other tick-borne illnesses soon. GLA and Ionica expect IonLyme to become very sensitive, and highly specific and for that reason very accurate.

Black-legged tickIxodes scapularis, a Black-legged tick/CDC

GLA has seeded Ionica Sciences with roughly $175,000 in funding to aid the event and launch from the test, which confirms the presence or lack of disease at or very near the start of signs and symptoms. GLA’s support, together with Cornell University’s Kevin M. McGovern Family Center for Venture Rise in the Existence Sciences, where Ionica Sciences is incubated, continues to be essential to the introduction of IonLyme.

“GLA requires a creative, innovative, and scientifically seem method of our research program, which is particularly important when looking for a reliable technology for Lyme diagnostics,” stated GLA Chairman Robert Kobre. “We think that by investing alongside Cornell’s venture arm, we are able to help Ionica change from early development to some commercially accessible, effective test. GLA makes targeted, initial phase investments so we have great confidence in Joel, Omar and every one of the Ionica team.”

Stated Omar Eco-friendly, Ph.D., Ionica’s Chief executive officer: “Without the support of GLA, IonLyme might have continued to be advisable on the white board. Now, using the generous support of GLA, Ionica Sciences is quickly creating a promising new technology which will transform Lyme disease testing because it is presently practiced.”

Early diagnosis is vital for Lyme, the most typical vector-borne disease within the U.S. with 329,000 new cases yearly. However, greater than 50 % of people are initially misdiagnosed because current exams are highly inaccurate. Most identify antibodies within the bloodstream that demonstrate contact with Lyme disease rather of targeting Borrelia burgdorferi, the bacteria which in turn causes the condition. Misdiagnosed individuals frequently go untreated and also the lingering infection may cause persistent debilitating signs and symptoms, including severe joint disease, memory and cognitive loss, and cardiac failure.

Read this month’s offers at Walk-In Lab! Offers finish in the finish from the month at 11:59pm PDT.

Today’s generally used two-tiered diagnostic test for Lyme disease measures the patient’s antibody reaction to a Lyme infection. Consequently, some patients may receive false negative test results since there hasn’t been sufficient time for antibodies to build up, or as their defense mechanisms might be covered up. However, Ionica’s test detects the existence of key Borrelia proteins in bloodstream using a highly sensitive spectrographic signature. It may identify early Lyme, track the progress from the disease and the potency of treatment.

“GLA thinks about the problem within the needs of patients who’ve been waiting a lengthy here we are at an evaluation that provides a far more precise diagnosis than current tests.” stated Scott Santarella, GLA’s Chief executive officer. “By purchasing industry we would like to generate the various tools to assist expedite a fix for your problem that will change up the lives of millions.”

Ionica wishes to bring the brand new IonLyme test towards the Fda for approval later in 2018.